Doxorubicin Completed Phase 1 Trials for Neoplasms / Hepatocellular,Carcinoma Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00988195Study of Pegylated Human Recombinant Arginase for Liver Cancer
NCT02081495A Study of DOXIL/CAELYX in Patients With Advanced or Refractory Solid Malignancies Including Patients With Ovarian Cancer